José Luis Nieva Escandon-rekin lankidetzan egindako argitalpenak (26)

2015

  1. Two-photon laurdan studies of the ternary lipid mixture DOPC:SM:Cholesterol reveal a single liquid phase at sphingomyelin:cholesterol ratios lower than 1

    Langmuir, Vol. 31, Núm. 9, pp. 2808-2817

2010

  1. Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains

    Chemistry and Biology, Vol. 17, Núm. 7, pp. 766-775

2003

  1. Calcium-dependent conformational changes of membrane-bound Ebola fusion peptide drive vesicle fusion

    FEBS Letters

  2. Interaction of Phospholipases C and Sphingomyelinase with Liposomes

    Methods in Enzymology, Vol. 372, pp. 3-19

2000

  1. Interactions of the HIV-1 fusion peptide with large unilamellar vesicles and monolayers. A cryo-TEM and spectroscopic study

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1467, Núm. 1, pp. 153-164

  2. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: Putative role during viral fusion

    Journal of Virology, Vol. 74, Núm. 17, pp. 8038-8047

  3. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: A novel fusogenic sequence

    FEBS Letters, Vol. 477, Núm. 1-2, pp. 145-149

1999

  1. Interbilayer lipid mixing induced by the human immunodeficiency virus type-1 fusion peptide on large unilamellar vesicles: The nature of the nonlamellar intermediates

    Chemistry and Physics of Lipids, Vol. 103, Núm. 1-2, pp. 11-20

  2. Membrane topology of the HIV-1 fusion peptide

    SPECTROSCOPY OF BIOLOGICAL MOLECULES: NEW DIRECTIONS

1998

  1. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus

    Journal of Virology, Vol. 72, Núm. 3, pp. 1775-1781

1997

  1. Membrane de stabilization induced by the human immunodeficiency virus type-1 fusion peptide

    International Journal of Peptide Research and Therapeutics, Vol. 4, Núm. 4-6, pp. 365-369

  2. Membrane destabilization induced by the human immunodeficiency virus type-1 fusion peptide

    LETTERS IN PEPTIDE SCIENCE

  3. Membrane fusion induced by the HIV type 1 fusion peptide: Modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds

    AIDS Research and Human Retroviruses, Vol. 13, Núm. 14, pp. 1203-1211

  4. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: Dose and sequence effects

    Biophysical Journal, Vol. 73, Núm. 4, pp. 1977-1986

1996

  1. Diacylglycerol and the promotion of lamellar-hexagonal and lamellar-isotropic phase transitions in lipids: Implications for membrane fusion

    Biophysical Journal, Vol. 70, Núm. 5, pp. 2299-2306

  2. Origin of the lag period in the phospholipase C cleavage of phospholipids in membranes. Concomitant vesicle aggregation and enzyme activation

    Biochemistry, Vol. 35, Núm. 48, pp. 15183-15187

1995

  1. Liposome destabilization induced by the HIV-1 fusion peptide Effect of a single amino acid substitution

    FEBS Letters, Vol. 362, Núm. 2, pp. 243-246

  2. Topological properties of two cubic phases of a phospholipid : cholesterol: diacylglycerol aqueous system and their possible implications in the phospholipase C-induced liposome fusion

    FEBS Letters, Vol. 368, Núm. 1, pp. 143-147

1994

  1. Interaction of the HIV-1 Fusion Peptide with Phospholipid Vesicles: Different Structural Requirements for Fusion and Leakage

    Biochemistry, Vol. 33, Núm. 11, pp. 3201-3209

  2. Phospholipase-C-promoted liposome fusion

    Biochemical Society Transactions